JPRN-UMIN000008921已完成未知
PC-SOD NE (Phase I) -Repeated Dose Study in healthy volunteers- - PC-SOD NE (Phase I)
TT Bio Pharma Co., LTD.0 个研究点目标入组 8 人开始时间: 2012年9月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 50years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •(1)BMI:<18.5 or >=25.0 (2)Exclusion criteria due to previous Cardiovascular system, blood systems, neuropsychiatric disorder, liver, kidney, respiratory system, endocrine system, alimentary system and a malignant tumor (3)Patients who are moderate intake of alcoholics, Patients of chemical dependency (4)Patients who are regular smokers (5)Patients of sensitive to any drug within 4 weeks. (6)Patients who took a prescribed drug within 4 weeks (7)Patients who obtained a blood sample of 200mL within 4 weeks or exceed 400mL within 12 weeks prior to the administration period of the study drug. (8)Patients who participated in another clinical study within 4 months prior to the administration period of the study drug. (9)Patients determined for other reasons not to be suitable to enter the current clinical study safety by PI or subinvestigators.
研究者
相似试验
已完成
1 期
PC-SOD NE(Phase I) -Single Dose Study in healthy volunteersidiopathic pulmonary fibrosisJPRN-UMIN000008920TT Bio Pharma Co., LTD.24
已完成
不适用
PC-SOD NE (PhaseIIa) -Repeated Dose Study in IPF patientsidiopathic pulmonary fibrosisJPRN-UMIN000009573TT Bio Pharma Co., LTD.4
已完成
不适用
Early Phase II clinical trial of PC-SOD -Study of the efficacy and safety of PC-SOD in patients with ulcerative colitisJPRN-UMIN000000753TT Bio-Pharma Co.,Ltd.40
已完成
不适用
Phase II double blind trial of PC-SOD in patients with idiopathic interstitial pneumoniasIdiopathic interstitial pneumonias(GradeIII to IV)JPRN-UMIN000000752TT Bio-Pharma Co.,Ltd.45
已完成
不适用
A study in healthy males to assess the safety and tolerability of two different formulations of the study drug, (MSP-2017), administered intranasally.This study is for healthy volunteers. The intended use of the investigational product is to self-terminate acute episodes of paroxysmal supraventricular tachycardia (PSVT), a non-life threatening cardiac arrhythmia.Cardiovascular - Coronary heart diseaseACTRN12613000971730CPR Pharma Services48